ImmuCell Corporation

Healthcare · Biotechnology · United States

Last price 10.26 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 93.18M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that improves the health and productivity of dairy and beef cattle in the United States and internationally. It operates through two segments, Scours and Mastitis. The company offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. It also provides California Mast...